Clinigen Group PLC with EPIC/TICKER (LON:CLIN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ today by analysts at Liberum Capital. Clinigen Group PLC are listed in the Health Care sector within AIM. Liberum Capital have set a target price of 850 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 37.1% from today’s opening price of 620 GBX. Over the last 30 and 90 trading days the company share price has increased 205 points and decreased 364 points respectively. The 52 week high for the share price is currently at 1069 GBX while the year low share price is currently 350.4 GBX.
Clinigen Group PLC has a 50 day moving average of 681.54 GBX and a 200 day moving average of 855.51. There are currently 132,848,758 shares in issue with the average daily volume traded being 698,738. Market capitalisation for LON:CLIN is £831,633,225 GBP.
